Annual Drug Patent Expirations for MAYZENT Mayzent is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Novartis drug MAYZENT appeared first on DrugPaten…
Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Veloxis Pharms drug ENVARSUS XR appeared first on Drug…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Italy. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…
Which pharmaceutical companies have the most SPCs in Italy? Read Post »
This chart shows the pharmaceutical companies with the most patents in Morocco. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pate…
Which pharmaceutical companies have the most drug patents in Morocco? Read Post »
Annual Drug Patent Expirations for EPIDIOLEX Epidiolex is a drug marketed by Gw Res Ltd and is included in one NDA. It is available from one supplier. There are twenty-two…
The post New patent for Gw Res drug EPIDIOLEX appeared first on DrugPatentWatch…
Annual Drug Patent Expirations for LUPKYNIS Lupkynis is a drug marketed by Aurinia and is included in one NDA. There are two patents protecting this drug. This drug has one…
The post New patent for Aurinia drug LUPKYNIS appeared first on DrugPatentWatc…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Austria. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Austria? Read Post »
This chart shows the companies which have received the most New Product exclusivities in the past five years. New Product Development is one of the categories for which the FDA…
The post Pharmaceutical companies with the most ‘New Product Exclusivity’ …
Pharmaceutical companies with the most ‘New Product Exclusivity’ drugs Read Post »
IXEMPRA KIT (ixabepilone) R-pharm us llc Patent: RE41393 Expiration: Aug 8, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations for the Wee…
Drug Patent Expirations for the Week of August 7, 2022 Read Post »
Annual Drug Patent Expirations for SUTAB Sutab is a drug marketed by Braintree Labs and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent for Braintree Labs drug SUTAB appeared first on DrugPatentWatc…
Get new actionable insights and updates from BiotechBlog
